Search research articles
Contact Us
Filters
Showing results (151-160 of 326) with videos related to
Page
of 33
Sort By:
Medicina Clinica
|
April 25, 1979
[The antigenic e system in carriers of the surface antigen of viral hepatitis B (author's transl)]
R Esteban, J D Pedreira, J Guardia, et al.
Medicina Clinica
|
April 1, 1982
[Serologic markers for hepatitis B virus in a group of healthy individuals (author's transl)]
V Vargas, J D Pedreira, R Esteban, et al.
Journal of Virological Methods
|
December 1, 1994
Comparative analysis of serological markers of chronic delta infection: HDV-RNA, serum HDAg and anti-HD IgM
R Jardi, M Buti, F Rodriguez, et al.
Lancet (London, England)
|
January 3, 1987
When should at-risk infants be boosted with hepatitis B vaccine?
L Viladomiu, J Genesca, J I Esteban, et al.
The Journal of Infectious Diseases
|
March 23, 2001
Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B
M Buti, F Sánchez, M Cotrina, et al.
British Medical Journal (Clinical Research Ed.)
|
November 14, 1981
Serum glutamate dehydrogenase in alcoholic liver disease
R Perez-Soler, M Cervantes, R M Segura, et al.
American Journal of Hematology
|
September 1, 1985
Liver involvement in multiple myeloma
R Perez-Soler, R Esteban, E Allende, et al.
Infection
|
June 23, 1999
Spontaneous non-typhoidal Salmonella peritonitis in patients with serious underlying disorders
J de la Fuente-Aguado, J Bordón, A R Esteban, et al.
Health Physics
|
July 12, 2008
Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy
R Barquero, F Basurto, H R Vega-Carrillo, et al.
Alimentary Pharmacology & Therapeutics
|
June 4, 2005
Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapy
M Buti, R Jardi, F Rodriguez-Frias, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 326) with videos related to
Sort By:
Page
of 33
Medicina Clinica
|
April 25, 1979
[The antigenic e system in carriers of the surface antigen of viral hepatitis B (author's transl)]
R Esteban, J D Pedreira, J Guardia, et al.
Medicina Clinica
|
April 1, 1982
[Serologic markers for hepatitis B virus in a group of healthy individuals (author's transl)]
V Vargas, J D Pedreira, R Esteban, et al.
Journal of Virological Methods
|
December 1, 1994
Comparative analysis of serological markers of chronic delta infection: HDV-RNA, serum HDAg and anti-HD IgM
R Jardi, M Buti, F Rodriguez, et al.
Lancet (London, England)
|
January 3, 1987
When should at-risk infants be boosted with hepatitis B vaccine?
L Viladomiu, J Genesca, J I Esteban, et al.
The Journal of Infectious Diseases
|
March 23, 2001
Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B
M Buti, F Sánchez, M Cotrina, et al.
British Medical Journal (Clinical Research Ed.)
|
November 14, 1981
Serum glutamate dehydrogenase in alcoholic liver disease
R Perez-Soler, M Cervantes, R M Segura, et al.
American Journal of Hematology
|
September 1, 1985
Liver involvement in multiple myeloma
R Perez-Soler, R Esteban, E Allende, et al.
Infection
|
June 23, 1999
Spontaneous non-typhoidal Salmonella peritonitis in patients with serious underlying disorders
J de la Fuente-Aguado, J Bordón, A R Esteban, et al.
Health Physics
|
July 12, 2008
Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy
R Barquero, F Basurto, H R Vega-Carrillo, et al.
Alimentary Pharmacology & Therapeutics
|
June 4, 2005
Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapy
M Buti, R Jardi, F Rodriguez-Frias, et al.
Page
of 33